Insider · CIK 0001197540
FISHERMAN JASON S
Reports to the SEC for 6 companies · BOSTON, MA
Transactions
50
Companies
6
Filings
10
CIK
0001197540
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCD Disposition to Issuer | −$9,450 |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCD Disposition to Issuer | −$567K |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer | — |
| 2020-01-28 | ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer | — |
| 2019-11-14 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion | — |
| 2019-11-14 | ACHILLION PHARMACEUTICALS INCM Exercise/Conversion | +$65.6K |
| 2019-01-23 | ACHILLION PHARMACEUTICALS INCStock Option (Right to buy)A Award | — |
| 2018-06-06 | ACHILLION PHARMACEUTICALS INCEmployee Stock OptionM Exercise/Conversion | — |
| 2018-06-06 | ACHILLION PHARMACEUTICALS INCM Exercise/Conversion | +$21K |
| 2018-02-09 | ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award | — |
| 2017-06-28 | ACHILLION PHARMACEUTICALS INCW Will/Inheritance | — |
| 2017-01-19 | ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award | — |
| 2016-12-22 | ACHILLION PHARMACEUTICALS INCP Purchase | +$39.6K |
| 2016-01-25 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2014-12-02 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2014-12-02 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2013-12-17 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2013-11-19 | ACHILLION PHARMACEUTICALS INCP Purchase | +$12.8K |
| 2013-11-18 | ACHILLION PHARMACEUTICALS INCP Purchase | +$26.7K |
| 2013-08-14 | ACHILLION PHARMACEUTICALS INCP Purchase | +$34.2K |
| 2013-06-21 | ACHILLION PHARMACEUTICALS INCP Purchase | +$76.3K |
| 2013-06-03 | ACHILLION PHARMACEUTICALS INCP Purchase | +$78.7K |
| 2012-12-18 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2011-12-12 | ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2011-07-21 | ACHILLION PHARMACEUTICALS INCS Sale | −$995.075 |
| 2011-07-20 | ACHILLION PHARMACEUTICALS INCS Sale | −$291.116 |
| 2011-07-19 | ACHILLION PHARMACEUTICALS INCS Sale | −$441.438 |
| 2011-07-18 | ACHILLION PHARMACEUTICALS INCS Sale | −$635.452 |
| 2011-07-15 | ACHILLION PHARMACEUTICALS INCS Sale | −$246.563 |
| 2011-07-15 | ACHILLION PHARMACEUTICALS INCS Sale | −$628.202 |
| 2011-07-14 | ACHILLION PHARMACEUTICALS INCS Sale | −$1,095.486 |
| 2011-07-13 | ACHILLION PHARMACEUTICALS INCS Sale | −$1,560.18 |
| 2011-07-12 | ACHILLION PHARMACEUTICALS INCS Sale | −$1,958.061 |
| 2011-07-11 | ACHILLION PHARMACEUTICALS INCS Sale | −$176.987 |
| 2011-07-11 | ACHILLION PHARMACEUTICALS INCS Sale | −$7.926 |
| 2011-07-08 | ACHILLION PHARMACEUTICALS INCS Sale | −$616.939 |
| 2010-12-16 | ACHILLION PHARMACEUTICALS INCStock OptionA Award | — |
| 2010-10-27 | Aegerion Pharmaceuticals, Inc.C Conversion | +$17.4K |
| 2010-10-27 | Aegerion Pharmaceuticals, Inc.C Conversion | — |
| 2010-10-27 | Aegerion Pharmaceuticals, Inc.C Conversion | — |
| 2010-10-27 | Aegerion Pharmaceuticals, Inc.P Purchase | +$7,020.5 |
| 2010-10-27 | Aegerion Pharmaceuticals, Inc.Series A Convertible Preferred StockC Conversion | — |
| 2010-10-27 | Aegerion Pharmaceuticals, Inc.Series B Convertible Preferred StockC Conversion | — |
| 2010-10-27 | Aegerion Pharmaceuticals, Inc.Senior Subordinated Convertible Promissory NotesC Conversion | — |
| 2010-10-21 | Aegerion Pharmaceuticals, Inc.Senior Suborinated Convertible Promissory NotesA Award | — |
Recent filings
- 4FISHERMAN JASON S0001562180-20-000670SEC(opens sec.gov)
- 4FISHERMAN JASON S0001562180-19-005524SEC(opens sec.gov)
- 4FISHERMAN JASON S0001209191-19-005376SEC(opens sec.gov)
- 4FISHERMAN JASON S0001209191-18-036667SEC(opens sec.gov)
- 4FISHERMAN JASON S0001209191-18-009666SEC(opens sec.gov)
- 4ACHILLION PHARMACEUTICALS INC0001209191-17-042522SEC(opens sec.gov)
- 4ACHILLION PHARMACEUTICALS INC0001209191-17-004614SEC(opens sec.gov)
- 4ACHILLION PHARMACEUTICALS INC0001209191-16-156623SEC(opens sec.gov)
- 4ACHILLION PHARMACEUTICALS INC0001209191-16-093851SEC(opens sec.gov)
- 4/AACHILLION PHARMACEUTICALS INC0001181431-14-038086SEC(opens sec.gov)
Companies
Address
C/O ADVENT INTERNATIONAL CORPORATION 75 STATE STREET
BOSTON, MA, 02109